171 related articles for article (PubMed ID: 31056603)
1. La esteroidogénesis en el síndrome de ovarios poliquísticos.
Ventura-Arizmendi E; Hernández-Valencia M
Gac Med Mex; 2019; 155(2):184-190. PubMed ID: 31056603
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Baskind NE; Balen AH
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
[TBL] [Abstract][Full Text] [Related]
3. Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.
Wang F; Zhang ZH; Xiao KZ; Wang ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):699-704. PubMed ID: 29125115
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
5. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.
McGee WK; Bishop CV; Bahar A; Pohl CR; Chang RJ; Marshall JC; Pau FK; Stouffer RL; Cameron JL
Hum Reprod; 2012 Feb; 27(2):531-40. PubMed ID: 22114112
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome in adolescent girls.
Baldauff NH; Witchel SF
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
Balen A
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
[TBL] [Abstract][Full Text] [Related]
8. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
10. [Polycystic ovary syndrome (author's transl)].
Lecomte P; Kuttenn F; Mauvais-Jarvis P
Nouv Presse Med; 1978 Feb; 7(5):355-6, 361-2. PubMed ID: 345233
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenaemia and the ovary.
Norman RJ
Mol Cell Endocrinol; 2002 May; 191(1):113-9. PubMed ID: 12044925
[TBL] [Abstract][Full Text] [Related]
12. [Polycystic ovary syndrome of extra-ovarian origin. Review].
Terán Dávila J; Teppa-Garrán AD
Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
[TBL] [Abstract][Full Text] [Related]
13. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome.
Goudas VT; Dumesic DA
Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
[TBL] [Abstract][Full Text] [Related]
15. Hypersecretion of luteinizing hormone and the polycystic ovary syndrome.
Balen AH
Hum Reprod; 1993 Nov; 8 Suppl 2():123-8. PubMed ID: 8276945
[TBL] [Abstract][Full Text] [Related]
16. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome.
Siegel SF; Lee PA
Curr Opin Pediatr; 1993 Aug; 5(4):400-6. PubMed ID: 8374664
[TBL] [Abstract][Full Text] [Related]
18. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
Allon MA; Leach RE; Dunbar J; Diamond MP
Fertil Steril; 2005 Apr; 83 Suppl 1():1319-26. PubMed ID: 15831308
[TBL] [Abstract][Full Text] [Related]
20. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
